Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery

NIH RePORTER · NIH · N01 · $206,138 · view on reporter.nih.gov ↗

Abstract

The proposed clinical trial will address whether daily application of endoxifene gel in escalating dose cohorts is tolerable and safe compared to placebo gel.

Key facts

NIH application ID
10173569
Project number
261201200035I-P00003-26100014-1
Recipient
NORTHWESTERN UNIVERSITY
Principal Investigator
Seema Khan
Activity code
N01
Funding institute
NIH
Fiscal year
2020
Award amount
$206,138
Award type
—
Project period
2017-09-15 → 2021-09-14